ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Receives Ethics Approval for Ross River Trial
Published: 22/05/17, 08:43am (AEST)•2 pages